Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study Of Panobinostat In Children With Refractory Hematologic Malignancies

This study has been completed.
Information provided by (Responsible Party):
Therapeutic Advances in Childhood Leukemia Consortium Identifier:
First received: March 21, 2011
Last updated: November 20, 2015
Last verified: November 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)